MedPath

Viberzi

These highlights do not include all the information needed to use VIBERZI safely and effectively. See full prescribing information for VIBERZI . VIBERZI (eluxadoline) tablets, for oral use , C IV Initial U.S. Approval: 2015

Approved
Approval ID

7821bd40-4c84-4984-951b-6436ae20421a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 1, 2020

Manufacturers
FDA

Allergan, Inc.

DUNS: 144796497

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Eluxadoline

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61874-075
Application NumberNDA206940
Product Classification
M
Marketing Category
C73594
G
Generic Name
Eluxadoline
Product Specifications
Route of AdministrationORAL
Effective DateNovember 13, 2023
FDA Product Classification

INGREDIENTS (12)

CROSPOVIDONE, UNSPECIFIEDInactive
Code: 2S7830E561
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
ELUXADOLINEActive
Quantity: 75 mg in 1 1
Code: 45TPJ4MBQ1
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990
Classification: IACT

Eluxadoline

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61874-100
Application NumberNDA206940
Product Classification
M
Marketing Category
C73594
G
Generic Name
Eluxadoline
Product Specifications
Route of AdministrationORAL
Effective DateNovember 13, 2023
FDA Product Classification

INGREDIENTS (12)

ELUXADOLINEActive
Quantity: 100 mg in 1 1
Code: 45TPJ4MBQ1
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
CROSPOVIDONE, UNSPECIFIEDInactive
Code: 2S7830E561
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Viberzi - FDA Drug Approval Details